Call Now

Central Retinal Vein Occlusion (CRVO)

The central retinal vein is the venous equivalent of the central retinal artery and, like that blood vessel, it can suffer from occlusion (central retinal vein occlusion, also CRVO), similar to that seen in ocular ischemic syndrome. Since the central retinal artery and vein are the sole source of blood supply and drainage for the retina, such occlusion can lead to severe damage to the retina and blindness, due to ischemia (restriction in blood supply) and edema (swelling). Treatment consists of Anti-VEGF drugs like Lucentis or intravitreal steroid implant (Ozurdex) and Pan-Retinal Laser Photocoagulation usually. Underlying conditions also require treatment. Non-Ischemic CRVO has better visual prognosis than Ischemic CRVO.

Organism species: Pan-species (General)

PRODUCT TYPE CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins N/A Recombinant Central Retinal Vein Occlusion (CRVO) Antigenic Transformation Customized Service Offer
Antibodies N/A Monoclonal Antibody to Central Retinal Vein Occlusion (CRVO) Monoclonal Antibody Customized Service Offer
N/A Polyclonal Antibody to Central Retinal Vein Occlusion (CRVO) Polyclonal Antibody Customized Service Offer
Assay Kits N/A CLIA Kit for Central Retinal Vein Occlusion (CRVO) CLIA Kit Customized Service Offer
N/A ELISA Kit for Central Retinal Vein Occlusion (CRVO) ELISA Kit Customized Service Offer